Journal of Biomedical Science and Engineering

Volume 4, Issue 9 (September 2011)

ISSN Print: 1937-6871   ISSN Online: 1937-688X

Google-based Impact Factor: 0.66  Citations  h5-index & Ranking

Mode of interaction of calcium oxalate crystal with human phosphate cytidylyltransferase 1: a novel inhibitor purified from human renal stone matrix

HTML  Download Download as PDF (Size: 1904KB)  PP. 591-598  
DOI: 10.4236/jbise.2011.49075    5,240 Downloads   9,657 Views  Citations

Affiliation(s)

.

ABSTRACT

Nephrolithiasis is a common clinical disorder, and calcium oxalate (CaOx) is the principal crystalline component in approximately 75% of all renal stones. It is widely believed that proteins act as inhibitors of crystal growth and aggregation. Acidic amino acids present in these proteins play a significant role in the inhibition process. In this study, interaction of cal-cium oxalate with human phosphate cytidylyltrans-ferase 1(CCT), a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix has been elucidated in silico and involvement of acidic amino acids in the same. As only sequence of CCT is available, henceforth its 3-D structure was modeled via Homology modeling using Prime module of Schrodinger package. Molecular dynamic simulation of modeled protein with solvation was done by mac-romodel (Schrodinger). The quality of modeled pro-tein was validated by JCSG protein structure valida-tion (PROCHECK & ERRAT) server. To analyze the interaction of modeled protein CCT with calcium oxalate along with role played by acidic amino acids, ‘Docking simulation’ was done using MOE–Dock. Interaction between calcium oxalate and CCT was also studied by substituting acidic amino acid in the active sites of the protein with neutral and positively charged amino acids. The in silico analysis showed the bond formation between the acidic amino acids and calcium atom, which was further substantiated when substitution of these acidic amino acids with alanine, glycine, lysine, arginine and histidine com-pletely diminished the interaction with calcium ox-alate.

Share and Cite:

Pathak, P. , Naik, P. , Sengupta, D. , Singh, S. and Tandon, C. (2011) Mode of interaction of calcium oxalate crystal with human phosphate cytidylyltransferase 1: a novel inhibitor purified from human renal stone matrix. Journal of Biomedical Science and Engineering, 4, 591-598. doi: 10.4236/jbise.2011.49075.

Cited by

[1] Oxidative stress and endoplasmic stress in calcium oxalate stone disease: the chicken or the egg?
2020
[2] Identification of novel human Serum Albumin (SA) inhibitors from Scoparia Dulsis for Urolithiasis
2020
[3] Kidney stone matrix proteins ameliorate calcium oxalate monohydrate induced apoptotic injury to renal epithelial cells
Life Sciences, 2016
[4] In silico Analysis of Protein
JSM Bioinformatics, Genomics and Proteomics, 2016
[5] Surface-modified bacterial nanofibrillar PHB scaffolds for bladder tissue repair
Artificial Cells, Nanomedicine, and Biotechnology, 2014
[6] Peeping into Human Renal Calcium Oxalate Stone Matrix: Characterization of Novel Proteins Involved in the Intricate Mechanism of Urolithiasis
PloS one, 2013
[7] Novel antilithiatic cationic proteins from human calcium oxalate renal stone matrix identified by MALDI-TOF-MS endowed with cytoprotective potential: An insight into the molecular mechanism of urolithiasis
Clinica Chimica Acta, 2013
[8] Nephrolithiasis: Molecular mechanism of renal stone formation and the critical role played by modulators-A Review I
2013
[9] Novel antilithiatic cationic proteins from human calcium oxalate renal stone matrix identified by MALDI-TOF-MS endowed with cytoprotective potential: An insight into …
Clinica Chimica Acta, 2013
[10] Nephrolithiasis: Molecular Mechanism of Renal Stone Formation and the Critical Role Played by Modulators
BioMed research international, 2013

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.